Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
PREVAC: Partnership for Research on Ebola Vaccines in Liberia, Guinea and Sierra Leon Vaccine Trial
Leidos Biomedical Research, Inc.
3/1/22 → 8/30/22
Project: Research project
-
Pre-Exposure Prophylaxis for Adults of High Risk of Occupational Exposure to Ebola Virus Trial (PREPARE)
Leidos Biomedical Research, Inc.
3/1/22 → 9/25/22
Project: Research project
-
Ebola Master Agreement / 21X184
Leidos Biomedical Research, Inc.
2/1/22 → 1/31/27
Project: Research project
-
COVID-19 Respiratory 003 (FLU003 Plus) INSIGHT 004 Influenza Genomics Study
Leidos Biomedical Research, Inc.
8/31/21 → 8/30/22
Project: Research project
-
ACTIV-3 INSIGHT 016 - VATICO-SARS-CoV-2 vaccination strategies in previously hospitalized and recovered COVID-19 patients
Leidos Biomedical Research, Inc.
5/1/21 → 6/30/22
Project: Research project
-
Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study
for the INSIGHT Clostridioides difficile Study Group & Young, J. A. H., Feb 2022, In: Transplant Infectious Disease. 24, 1, e13770.Research output: Contribution to journal › Article › peer-review
-
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
Murray, D. D., Babiker, A. G., Baker, J. V., Barkauskas, C. E., Brown, S. M., Chang, C. C., Davey, V. J., Gelijns, A. C., Ginde, A. A., Grund, B., Higgs, E., Hudson, F., Kan, V. L., Lane, H. C., Murray, T. A., Paredes, R., Parmar, M. K. B., Pett, S., Phillips, A. N., Polizzotto, M. N. & 8 others, , Feb 2022, In: Clinical Trials. 19, 1, p. 52-61 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
The ITAC (INSIGHT 013) Study Group, Feb 5 2022, In: The Lancet. 399, 10324, p. 530-540 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels: A Randomized Controlled Trial
Lundgren, J. D., Grund, B., Barkauskas, C. E., Holland, T. L., Gottlieb, R. L., Sandkovskyc, U., Brownc, S. M., Knowlton, K. U., Self, W. H., Files, D. C., Jain, M. K., Benfield, T., Bowdishc, M. E., Leshnower, B. G., Bakerc, J. V., Jensen, J. U., Gardner, E. M., Ginde, A. A., Harris, E. S., Johansen, I. S. & 33 others, , Feb 1 2022, In: Annals of internal medicine. 175, 2, p. 234-243 10 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
A neutralizing monoclonal antibody for hospitalized patients with Covid-19
ACTIV-3/TICO LY-CoV555 Study Group, Mar 11 2021, In: New England Journal of Medicine. 384, 10, p. 905-914 10 p.Research output: Contribution to journal › Article › peer-review
Open Access160 Scopus citations
Press / Media
-
Eli Lilly's antibody trial is paused over potential safety concerns
10/14/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
University of Minnesota leads recruitment to new COVID-19 antibody trial
10/14/20
1 item of Media coverage
Press/Media: Expert Comment or Interview